Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Jupiter Neurosciences, Inc. (JUNS) had Consolidated Net Income/Loss of $-2.44M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-2.44M |
|
-- |
|
-- |
|
$3.09M |
|
$-3.09M |
|
$0.65M |
|
$-2.44M |
|
$-2.44M |
|
$-2.44M |
|
$-2.44M |
|
|
Consolidated Net Income/Loss |
$-2.44M |
$-2.44M |
|
$-3.09M |
|
$-3.05M |
|
28.78M |
|
28.78M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$4.65M |
|
-- |
|
$1.55M |
|
$6.20M |
|
$2.01M |
|
-- |
|
$0.02M |
|
$2.03M |
|
$4.17M |
|
$4.17M |
|
$4.17M |
|
33.10M |
|
| Cash Flow Statement Financials | |
$-3.91M |
|
-- |
|
$7.65M |
|
$0.03M |
|
$3.77M |
|
$3.74M |
|
$1.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.31 |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.48% |
|
-58.48% |
|
-39.33% |
|
-58.48% |
|
$0.13 |
|
$-0.14 |
|
$-0.14 |
|